Related Experiment Video
Updated: Mar 19, 2026
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
E2-2, a novel immunohistochemical marker for both human and monkey plasmacytoid dendritic cells
Jianping Ma1,2, Haisheng Yu1,2, Xiangyun Yin1,2
1Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101 China.
Researchers developed a novel antibody targeting the E2-2 transcription factor to specifically identify plasmacytoid dendritic cells (pDCs). This new tool aids in studying pDC roles in diseases like infections, tumors, and autoimmune conditions.
Area of Science:
- Immunology
- Cell Biology
Background:
- Plasmacytoid dendritic cells (pDCs) are crucial immune regulators involved in various diseases.
- pDC infiltration severity often correlates with disease progression.
- A specific antibody for immunohistochemical identification of pDCs in tissues is needed.
Purpose of the Study:
- To develop a novel antibody for specific detection of pDCs.
- To validate the antibody's utility in immunohistochemical staining.
Main Methods:
- Development of a novel antibody targeting the E2-2 transcription factor.
- Immunohistochemical staining of various human and rhesus monkey tissues.
Main Results:
- The novel antibody specifically stains the nuclei of pDCs.
- Successful identification of pDCs in diverse tissue types.
Conclusions:
- A specific antibody for pDC identification has been successfully developed.
- This antibody is a valuable tool for pDC research and clinical studies.
More Related Videos
09:49Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine Peyer's Patches
Published on: March 17, 2013
06:12Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022